EG-007
- Generic Name
- EG-007
Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem
Phase 2
Not yet recruiting
- Conditions
- Advanced Endometrial Cancer
- Interventions
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Evergreen Therapeutics, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT05106127
Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer
Phase 3
Not yet recruiting
- Conditions
- Advanced Endometrial Cancer
- Interventions
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Evergreen Therapeutics, Inc.
- Target Recruit Count
- 450
- Registration Number
- NCT05077215
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath